Schroder Investment Management Group
ANIK icon

Schroder Investment Management Group’s Anika Therapeutics ANIK Stock Holding History

Schroder Investment Management Group’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-4,000
Closed -$153K – 1424
2013
Q4 		$153K Sell
4,000
-78,800
-95% -$2.43M ﹤0.01% 1248
2013
Q3 		$1.98M Sell
82,800
-47,713
-37% -$1.07M ﹤0.01% 918
2013
Q2 		$2.22M Buy
+130,513
New +$1.88M 0.01% 879

Other funds holding ANIK

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Schroder Investment Management Group's ANIK Position: Q1 2014 in Review

Schroder Investment Management Group sold out of Anika Therapeutics (ANIK) in Q1 2014, closing a stake of 4,000 shares — an estimated $153K sold.

Schroder Investment Management Group first reported a position in ANIK in Q2 2013 and held it in 3 quarters. The position peaked at $2.22M in Q2 2013. 153 funds tracked by Wall St. Rank hold ANIK as of Q1 2014.

  • Schroder Investment Management Group reported no remaining Anika Therapeutics position as of Q1 2014 after selling out during the quarter.
  • Schroder Investment Management Group sold 4,000 Anika Therapeutics shares in Q1 2014, an estimated $153K.
  • Schroder Investment Management Group first reported a position in Anika Therapeutics in Q2 2013 and held it in 3 quarters.
  • Schroder Investment Management Group's Anika Therapeutics position peaked at $2.22M in Q2 2013.
  • 153 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2014.

Based on Schroder Investment Management Group's 13F filing for Q1 2014, filed 15 May 2014.